M Medtronic PLC
| Market Cap | $111.22B |
| P/E Ratio | 24.20 |
| Forward P/E | 14.29 |
| Dividend Yield | 3.28% |
| Beta | 0.76 |
| 52W Range | $78.19 - $103.73 |
| # Hedge Funds | 8 |
| Sector | Healthcare |
| Industry | Medical Devices |
Hedge Fund Ownership
| Investor 8 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| David Katz Matrix Asset Advisors | 3.19% | $35.50M | 369,541 | Reduce 0.29% |
| First Eagle Investment Management First Eagle Investment Management | 1.65% | $939.01M | 9,775,234 | Add 0.41% |
| Robert Olstein Olstein Capital Management | 1.61% | $7.00K | 73,000 | Reduce 16.09% |
| Richard Pzena Pzena Investment Management | 0.93% | $309.20M | 3,218,852 | Reduce 45.70% |
| Dodge & Cox Dodge & Cox | 0.40% | $743.32M | 7,738,043 | Add 0.17% |
| Mairs & Power Growth Fund Mairs & Power Inc | 0.38% | $39.65M | 412,750 | Reduce 4.14% |
| Hillman Value Fund Hillman Capital Management | 0.23% | $359.00K | 3,739 | Reduce 0.24% |
| Polen Capital Management Polen Capital Management | 0.03% | $8.12M | 84,500 | Reduce 32.38% |
Insider Trading
| Insider Name of the company insider who made the trade 19 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| KIIL HARRY SKIPEVP & President Cardiovascular | Sale | 668 | $97.83 | $65.35K | 19 Feb 2026 | 26 Feb 2026 |
| KIIL HARRY SKIPEVP & President Cardiovascular | Sale | 30,568 | $97.66 | $2.99M | 19 Feb 2026 | 26 Feb 2026 |
| KIIL HARRY SKIPEVP & President Cardiovascular | Sale | 385 | $97.82 | $37.66K | 19 Feb 2026 | 26 Feb 2026 |
| KIIL HARRY SKIPEVP & President Cardiovascular | Sale | 19,255 | $97.77 | $1.88M | 19 Feb 2026 | 26 Feb 2026 |
| KIIL HARRY SKIPEVP & President Cardiovascular | Sale | 1,648 | $97.86 | $161.27K | 19 Feb 2026 | 26 Feb 2026 |
| Smith Gregory LEVP Global Ops & Supply Chain | Sale | 325 | $102.06 | $33.17K | 19 Nov 2025 | 21 Nov 2025 |
| Smith Gregory LEVP Global Ops & Supply Chain | Sale | 227 | $102.05 | $23.17K | 19 Nov 2025 | 21 Nov 2025 |
| Smith Gregory LEVP Global Ops & Supply Chain | Sale | 1,942 | $101.99 | $198.06K | 19 Nov 2025 | 21 Nov 2025 |
| Smith Gregory LEVP Global Ops & Supply Chain | Sale | 500 | $102.08 | $51.04K | 19 Nov 2025 | 21 Nov 2025 |
| Smith Gregory LEVP Global Ops & Supply Chain | Sale | 825 | $102.04 | $84.18K | 19 Nov 2025 | 21 Nov 2025 |
| Smith Gregory LEVP Global Ops & Supply Chain | Sale | 1,995 | $102.03 | $203.55K | 19 Nov 2025 | 21 Nov 2025 |
| Smith Gregory LEVP Global Ops & Supply Chain | Sale | 24,186 | $101.93 | $2.47M | 19 Nov 2025 | 21 Nov 2025 |
| Gregory L SmithEVP Global Ops & Supply Chain | Sale | 325 | $102.06 | $33.17K | 19 Nov 2025 | 21 Nov 2025 |
| Gregory L SmithEVP Global Ops & Supply Chain | Sale | 227 | $102.05 | $23.17K | 19 Nov 2025 | 21 Nov 2025 |
| Gregory L SmithEVP Global Ops & Supply Chain | Sale | 1,942 | $101.99 | $198.06K | 19 Nov 2025 | 21 Nov 2025 |
| Gregory L SmithEVP Global Ops & Supply Chain | Sale | 500 | $102.08 | $51.04K | 19 Nov 2025 | 21 Nov 2025 |
| Gregory L SmithEVP Global Ops & Supply Chain | Sale | 825 | $102.04 | $84.18K | 19 Nov 2025 | 21 Nov 2025 |
| Gregory L SmithEVP Global Ops & Supply Chain | Sale | 1,995 | $102.03 | $203.55K | 19 Nov 2025 | 21 Nov 2025 |
| Gregory L SmithEVP Global Ops & Supply Chain | Sale | 24,186 | $101.93 | $2.47M | 19 Nov 2025 | 21 Nov 2025 |
Frequently Asked Questions
What is MDT stock price today?
Medtronic PLC (MDT) is currently trading at $86.63. The stock has a 52-week range of $78.19 to $103.73 and a market capitalization of $111.22B.
Is MDT a good stock to buy in 2026?
Medtronic PLC has a P/E ratio of 24.2 (forward P/E: 14.3), a dividend yield of 3.28%, and 1-year performance of +1.7%. 8 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling MDT stock?
There have been 19 insider transactions for MDT in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has MDT stock performed over the past year?
Medtronic PLC (MDT) has returned +1.7% over the past 12 months. The stock traded between $78.19 and $103.73 during this period, and is currently at $86.63.
Which hedge funds own MDT (Medtronic PLC)?
8 tracked hedge funds currently hold MDT in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is MDT's market cap and valuation?
Medtronic PLC (MDT) has a market capitalization of $111.22B. The trailing P/E ratio is 24.2 and forward P/E is 14.3. The stock is classified in the Healthcare sector.
What is MDT's revenue and profitability?
Medtronic PLC reported revenue of $35.48B with net income of $4.61B and a profit margin of 0.13%. The stock has a beta of 0.76.
What sector is MDT in and who are its biggest institutional holders?
Medtronic PLC (MDT) operates in the Healthcare sector. It is held by 8 tracked hedge funds. See the ownership table above for the complete list.